NCT01694641

Brief Summary

A multiple pregnancy is an undesired outcome of assisted reproduction. Current embryo selection technologies are inefficient in identifying the embryo with the highest implantation potential. Time lapse (TL) embryo monitoring provides additional information about embryo development and therefore may aid embryo selection. The investigators aim is to study whether TL monitoring is superior to traditional embryo observation when a single blastocyst is selected for transfer (ET).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
161

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jul 2012

Typical duration for phase_4

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 21, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 27, 2012

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

December 29, 2016

Completed
Last Updated

February 13, 2018

Status Verified

January 1, 2018

Enrollment Period

2.8 years

First QC Date

September 21, 2012

Results QC Date

November 2, 2016

Last Update Submit

January 16, 2018

Conditions

Keywords

time lapse monitoringblastocystsingle embryo transferclinical pregnancyimplantation rate

Outcome Measures

Primary Outcomes (1)

  • Pregnancy Rate

    rise in beta HCG 12-14 days after transfer

    12-14 days after transfer

Secondary Outcomes (1)

  • Live Birth

    delivery after 24 weeks

Other Outcomes (2)

  • Time Lapse Score

    the time lapse score is assessed on the day of embryo transfer (day 5 after the egg retrieval)

  • Perinatal Outcome

    perinatal outcome assessed after delivery

Study Arms (2)

time-lapse morphokinetic evaluation

EXPERIMENTAL

Embryo selection for transfer based on a combind score made up of scores for kinetic parameters and standard morphology as seen on time-lapse: upon fertilization embryos in a petri dish that allows individual assessment (Primo Vision Dish) are placed onto an automated time-lapse equipment in an incubator. The time-lapse equipment performs imaging in 10 minutes intervals. The software is presenting the up-to-date images and allows the operator to assess the "time-lapse" movie of the developmental history of the embryos to perform annotations and apply evaluation/selection algorithm. This morpho-kinetic TL algorithm (made up of standard moprhology as seen on time lapse and kinetci scores) is used for embryo selection, which actually describes the intervention.

Other: time-lapse morphokinetic evaluation

standard embryo monitoring

NO INTERVENTION

Upon fertilization embryos are observed once on days 1-3-5 by the embryologist to check for development. The single embryo for transfer is selected based on actual morphology as seen under light microscope.

Interventions

embryo selection for transfer based on a combind score made up of scores for kinetic parameters and standard morphology as seen on time-lapse

Also known as: time-lapse morphokintic score
time-lapse morphokinetic evaluation

Eligibility Criteria

Age18 Years - 36 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age \< 36 yrs
  • baseline FSH \<10 IU/l
  • regular 25-35 day cycles
  • less than 2 previous failed IVF cycles
  • intact uterus
  • an indication for IVF
  • BMI \<18- \<30 kg/m2
  • acceptance of single embryo transfer

You may not qualify if:

  • PCOS
  • Sperm obtained by surgical extraction
  • chromosome abnormality
  • Presence of hydrosalpinx
  • stage III/IV endometriosis
  • Less than 3 good quality day 3 embryos
  • only one good quality day 5 embryos
  • lack of consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kaali Institute IVF Center

Budapest, 1125, Hungary

Location

Forgacs Intezet

Budapest, 1205, Hungary

Location

Related Publications (3)

  • Pribenszky C, Matyas S, Kovacs P, Losonczi E, Zadori J, Vajta G. Pregnancy achieved by transfer of a single blastocyst selected by time-lapse monitoring. Reprod Biomed Online. 2010 Oct;21(4):533-6. doi: 10.1016/j.rbmo.2010.04.015. Epub 2010 Apr 24.

    PMID: 20638906BACKGROUND
  • Pribenszky C, Losonczi E, Molnar M, Lang Z, Matyas S, Rajczy K, Molnar K, Kovacs P, Nagy P, Conceicao J, Vajta G. Prediction of in-vitro developmental competence of early cleavage-stage mouse embryos with compact time-lapse equipment. Reprod Biomed Online. 2010 Mar;20(3):371-9. doi: 10.1016/j.rbmo.2009.12.007. Epub 2010 Jan 25.

    PMID: 20089456BACKGROUND
  • Meseguer M, Herrero J, Tejera A, Hilligsoe KM, Ramsing NB, Remohi J. The use of morphokinetics as a predictor of embryo implantation. Hum Reprod. 2011 Oct;26(10):2658-71. doi: 10.1093/humrep/der256. Epub 2011 Aug 9.

    PMID: 21828117BACKGROUND

Limitations and Caveats

The downside of the study demographics is that we limited the study population to good prognosis cases therefore the conclusions can only be applied to similar patients. Stopped the study before meeting calculated sample size.

Results Point of Contact

Title
Dr Peter Kovacs
Organization
Kaali Inst. IVF Center

Study Officials

  • Peter Kovacs, MD

    Kaali Inst. IVF Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 21, 2012

First Posted

September 27, 2012

Study Start

July 1, 2012

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

February 13, 2018

Results First Posted

December 29, 2016

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations